Yabao goes bold China-based Yabao Pharmaceutical Group Co. Ltd. and MRC Technology are jointly going where Western pharmas and academics fear to tread with a preclinical partnership to develop compounds against an undisclosed kinase target...

Nuvilex and the university partnered to conduct preclinical studies of Nuvilex's Cell-in-a-Box cellulose-based, live-cell encapsulation technology to treat diabetes under a two-year initial deal. The university will evaluate the tumorigenicity of an insulin-producing cell line,...